Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
Seminars in Radiation Oncology|September 24, 2011
Radiation therapy for liver metastasesTracey E Schefter, Brian D KavanaghJournal of Applied Clinical Medical Physics|May 30, 2007
The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumorsBrian D Kavanagh, Meisong Ding, Tracey E Schefter, et al.International Journal of Radiation Oncology, Biology, Physics|April 13, 2012
Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastasesMichelle A Stinauer, Quentin Diot, David C Westerly, et al.International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastasesTracey E Schefter, Brian D Kavanagh, Robert D Timmerman, et al.Medical Physics|August 17, 2012
High-dose MVCT image guidance for stereotactic body radiation therapyDavid C Westerly, Tracey E Schefter, Brian D Kavanagh, et al.International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastasesChristopher C Howells, Michelle A Stinauer, Quentin Diot, et al.Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancerTracey E Schefter, Brian D Kavanagh, Qiuwen Wu, et al.Seminars in Radiation Oncology|July 16, 2002
Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancerBrian D Kavanagh, Tracey E Schefter, Qiuwen Wu, et al.Hepatic Oncology|September 8, 2018
Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastasesChad G Rusthoven, Tracey E SchefterOncotargets and Therapy|December 8, 2015
Profile of bevacizumab and its potential in the treatment of cervical cancerChristine M Fisher, Tracey E SchefterPageof 15